0

Hormonal Contraception and Breast Cancer Risk

White ND, 2018

American journal of lifestyle medicine, 12(3), 224-226

DOI 10.1177/1559827618754833 PMID 30283254 Source

Abstract

Contemporary hormonal contraception formulations contain lower doses of estrogen, have new synthetic progestin components, and provide novel methods of delivery that have not been studied extensively in relation to breast cancer risk. Given that hormonal contraception is the leading method of birth control in the United States, it is important to reevaluate risk using current formulations. Recent studies including contemporary hormonal contraception formulations will be described.

Topics

Contraception/Comparison > Side Effects > Hormonal ContraceptionEthics/Philosophy > Informed Consent > Reproductive Procedures
birth control pills breast cancer risk, hormonal contraception cancer safety, oral contraceptive breast cancer link, contraceptive pill health risks, hormonal birth control long term effects, progestin breast cancer risk, low dose estrogen contraception safety, birth control side effects breast tissue, contemporary hormonal contraception risks, contraceptive methods breast cancer comparison

Cite this article

White, N. D. (2018). Hormonal Contraception and Breast Cancer Risk. *American journal of lifestyle medicine*, *12*(3), 224-226. https://doi.org/10.1177/1559827618754833

Related articles